List of Figures:
Figure 2-1: Reduction in Time & Cost (%) by Using Computer Aided Drug Design Method
Figure 2-2: Worldwide - Forecast for Number of Drugs Facing Patent Expirations* (2007-2011)
Figure 2-3: Worldwide - Forecast for Loss due to Drug Patent Expirations* (in Billion US$), 2007-2011
Figure 3-1: Worldwide - Bioinformatics Market (in Million US$), 2002-2006E
Figure 3-2: Worldwide - Forecast for Bioinformatics Market (in Million US$), 2007-2010
Figure 3-3: US - Share in Global Bioinformatics Market (%), 2007F
Figure 3-4: Europe - Bioinformatics Market (in Million US$), 2004 & 2006
Figure 3-5: Europe - Percentage of R&D Spending & Drugs in Pipeline by Company Size, 2004
Figure 3-6: Europe - Forecast for Bioinformatics Market (in Million US$), 2007-2013
Figure 3-7: Japan - Bioinformatics Market (in Billion Yen), 2001-2003
Figure 3-8: India - Bioinformatics Market (in Rs Crore), 2002-03 to 2006-07
Figure 3-9: India - Share of Exports & Domestic Market in Bioinformatics Industry (%), 2006-07
Figure 3-10: South Korea - Bioinformatics Market, Exports & Imports (in ‘000 US$), 2004
Figure 3-11: Taiwan - Bioinformatics Market (in Million US$), 2001-2003E & 2006E
Figure 3-12: Taiwan - Bioinformatics Market Imports (in Million US$), 2001-2003E & 2006E
Figure 3-13: Australia - Biotech Companies by Sector (%), 2006
Figure 3-14: Worldwide - Bioinformatics Market by Segment (%), 2006E
Figure 3-15: Worldwide - Forecast for Bioinformatics Market by Segment (%), 2010
Figure 3-16: Worldwide - Analysis Software & Services Market (in Million US$), 2005 & 2006E
Figure 3-17: Worldwide - Forecast for Analysis Software & Services Market (in Million US$), 2007–2010
Figure 3-18: Worldwide - Analysis Software & Services Market by Application (%), 2006E
Figure 3-19: Worldwide - Forecast for Analysis Software & Services Market by Application (%), 2009
Figure 3-20: Worldwide - Content Market (in Million US$), 2005 & 2006E
Figure 3-21: Worldwide - Forecast for Content Market (in Million US$), 2007-2010
Figure 3-22: Worldwide - IT Infrastructure & Other Services Market (in Million US$), 2005 & 2006E
Figure 3-23: Worldwide - Forecast for IT Infrastructure & Other Services Market (in Million US$), 2007-2010
Figure 3-24: Worldwide - Bioinformatics Market by Application (%), 2001
Figure 3-25: Worldwide - Genomics Market (in Billion US$) 2002 & 2006E
Figure 3-26: Worldwide - Forecast for Genomics Market (in Billion US$), 2007-2009
Figure 3-27: Worldwide - DNA Sequencing & Proteomics Market (in Billion US$), 2004-2006E
Figure 3-28: Worldwide - Forecast for DNA Sequencing & Proteomics Market (in Billion US$), 2007-2009
Figure 3-29: Worldwide - Application of Proteomics in Bioinformatics Market (in Million US$), 2005-2007
Figure 3-30: Worldwide - Pharmacogenomics Market by Core Segment (in Million US$), 2004-2006E
Figure 3-31: Worldwide - Forecast for Pharmacogenomics Market by Core Segment (in Million US$), 2007-2009
Figure 3-32: Worldwide - Pharmacogenomics Market (in Million US$), 2004-2006E
Figure 3-33: Worldwide - Forecast for Pharmacogenomics Market (in Million US$), 2007-2009
Figure 3-34: Worldwide - Application of Pharmacogenomics in Bioinformatics Market (in Million US$), 2005-2007E
Figure 3-35: Worldwide - Drug Discovery Expenditure (in Billion US$), 2002 & 2006E
Figure 4-1: Worldwide - Drug Delivery Market (in Billion US$), 2005 & 2006E
Figure 4-2: Worldwide - Forecast for Drug Delivery Market (in Billion US$), 2007–2010
List of Tables:
Table 3-1: Growth in Key Bioinformatics Databases (December 2004 & December 2005)
Table 5-1: Accelrys, Inc. - Key Financials (in Million US$), 2005-2007
Table 5-2: Affymetrix, Inc. - Key Financials (in Million US$), 2004-2006
Table 5-3: Applied Biosystems Group - Key Financials (in Million US$), 2004-2006
Table 5-4: Celera Genomics Group - Key Financials (in Million US$), 2004-2006
Table 5-5: Ciphergen Biosystems - Key Financials (in Millions US$), 2004-2006
Table 5-6: Compugen Ltd. - Key Financials (in Million US$), 2004-2006
Table 5-7: CuraGen Corporation - Key Financials (in Million US$), 2004-2006
Table 5-8: Gene Logic Inc. - Key Financials (in Million US$), 2004-2006
Table 5-9: Incyte Corporation - Key Financials (in Million US$), 2004-2006
Table 5-10: Tripos, Inc. - Key Financials (in Million US$), 2004-2006
